The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Attenuated Sympathetic Activity and Its Relation to Obesity in MSG Injected and Sympathectomized Rats

  • Park, So-Young (Department of Physiology, College of Medicine, Yeungnam University) ;
  • Kim, Yong-Woon (Department of Physiology, College of Medicine, Yeungnam University) ;
  • Dan, Jin-Myoung (Department of Physiology, College of Medicine, Yeungnam University) ;
  • Kim, Jong-Yeon (Department of Physiology, College of Medicine, Yeungnam University)
  • Published : 2007.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

In order to characterize the role of sympathetic activity in obesity, we repeatedly assessed sympathetic activity via power spectral analyses of heart rate variability in the same subjects at 7, 11, 25, and 60 weeks, using monosodium glutamate (MSG)-induced obese and control rats. The effects of lower sympathetic activity on obesity were also evaluated. Fat mass in MSG rats was already higher at 7 weeks, but the sympathetic activity did not differ between 7 and 25 weeks. Between 25 and 60 weeks, the increase in fat mass, food efficiency, and body weight gain was higher in MSG rats. The increase in sympathetic activity between 25 and 60 weeks and sympathetic activity at 60 weeks were lower in MSG rats. Fat mass at 60 weeks was inversely correlated with changes in sympathetic activity between 25 and 60 weeks. Reduced plasma epinephrine levels by bilateral adrenal demedullation induced increase of fat mass. In, an attenuated increase of sympathetic activity with age may partly be responsible for aggravated obesity in MSG rats. Additionally, reduced sympathetic activity per se induced obesity in rats. These results suggest that lower sympathetic activity contributes to obesity in rats.

Keywords

References

  1. Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Goth MI, Koltowska-Haggstrom M, Monson JP, Verhelst J, Wilton P. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Horm IGF Res 15: 349-359, 2005 https://doi.org/10.1016/j.ghir.2005.06.018
  2. Astrup A. Thermogenesis in human brown adipose tissue and skeletal muscle induced by sympathomimetic stimulation. Acta Endocrinol Suppl (Copenh) 278: 1-32, 1986
  3. Barbagallo CM, Cavera G, Sapienza M, Noto D, Cefalu AB, Pagano M, Montalto G, Notarbartolo A, Averna MR. Prevalence of overweight and obesity in a rural southern Italy population and relationships with total and cardiovascular mortality: the Ventimiglia di Sicilia project. Int J Obes Relat Metab Disord 25: 185-190, 2001 https://doi.org/10.1038/sj.ijo.0801321
  4. Bray GA. Sympathetic nervous system, adrenergic receptors, and obesity. J Lab Clin Med 134: 4-6, 1999 https://doi.org/10.1016/S0022-2143(99)90047-1
  5. Collins S, Surwit RS. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog Horm Res 56: 309-328, 2001 https://doi.org/10.1210/rp.56.1.309
  6. Cummings DE, Merriam GR. Age-related changes in growth hormone secretion: should the somatopause be treated? Semin Reprod Endocrinol 17: 311-325, 1999 https://doi.org/10.1055/s-2007-1016241
  7. Flechtner-Mors M, Ditschuneit HH, Yip I, Adler G. Sympathetic modulation of lipolysis in subcutaneous adipose tissue: effects of gender and energy restriction. J Lab Clin Med 134: 33-41, 1999 https://doi.org/10.1016/S0022-2143(99)90051-3
  8. Gao YY, Lovejoy JC, Sparti A, Bray GA, Keys LK, Partington C. Autonomic activity assessed by heart rate spectral analysis varies with fat distribution in obese women. Obes Res 4: 55-63, 1996 https://doi.org/10.1002/j.1550-8528.1996.tb00512.x
  9. Giovambattista A, Suescun MO, Nessralla CC, Franca LR, Spinedi E, Calandra RS. Modulatory effects of leptin on leydig cell function of normal and hyperleptinemic rats. Neuroendocrinology 78: 270-279, 2003 https://doi.org/10.1159/000074448
  10. Hofbauer KG. Molecular pathways to obesity. Int J Obes Relat Metab Disord 26 Suppl 2: S18-S27, 2002
  11. Ivanisevic-Milovanovic OK, Demajo M, Loncar-Stevanovic H, Karakasevic A, Pantic V. Basal and stress induced concentrations of adrenal gland catecholamines and plasma ACTH during aging. Acta Physiol Hung 85: 65-75, 1997
  12. Johnson EM Jr, O'Brien F, Werbitt R. Modification and characterization of the permanent sympathectomy produced by the administration of guanethidine to newborn rats. Eur J Pharmacol 37: 45-54, 1976 https://doi.org/10.1016/0014-2999(76)90006-6
  13. Kim YW, Kim JY, Lee SK. Surgical removal of visceral fat decreases plasma free fatty acid and increases insulin sensitivity on liver and peripheral tissue in monosodium glutamate (MSG)-obese rats. J Korean Med Sci 14: 539-545, 1999 https://doi.org/10.3346/jkms.1999.14.5.539
  14. Kuwahara M, Yayou K, Ishii K, Hashimoto S, Tsubone H, Sugano S. Power spectral analysis of heart rate variability as a new method for assessing autonomic activity in the rat. J Electrocardiol 27: 333-337, 1994 https://doi.org/10.1016/S0022-0736(05)80272-9
  15. Leigh FS, Kaufman LN, Young JB. Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats. Int J Obes Relat Metab Disord 16: 597- 604, 1992
  16. Li PP, Shan S, Chen YT, Ning ZQ, Sun SJ, Liu Q, Lu XP, Xie MZ, Shen ZF. The PPARalpha/gamma dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats. Br J Pharmacol 148: 610-618, 2006 https://doi.org/10.1038/sj.bjp.0706745
  17. Mabry TR, Gold PE, McCarty R. Age-related changes in plasma catecholamine responses to chronic intermittent stress. Physiol Behav 58: 49-56, 1995 https://doi.org/10.1016/0031-9384(94)00387-K
  18. Martini G, Riva P, Rabbia F, Molini V, Ferrero GB, Cerutti F, Carra R, Veglio F. Heart rate variability in childhood obesity. Clin Auton Res 11: 87-91, 2001 https://doi.org/10.1007/BF02322051
  19. Martins AC, Souza KL, Shio MT, Mathias PC, Lelkes PI, Garcia RM. Adrenal medullary function and expression of catecholaminesynthesizing enzymes in mice with hypothalamic obesity. Life Sci 74: 3211-3222, 2004 https://doi.org/10.1016/j.lfs.2003.10.034
  20. Matsumura K, Abe I, Tsuchihashi T, Fujishima M. Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. Am J Physiol Regul Integr Comp Physiol 278: R1314-R1320, 2000 https://doi.org/10.1152/ajpregu.2000.278.5.R1314
  21. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002 https://doi.org/10.1038/415339a
  22. Mueller RA, Thoenen H, Axelrod J. Adrenal tyrosine hydroxylase: compensatory increase in activity after chemical sympathectomy. Science 163: 468-469, 1969 https://doi.org/10.1126/science.163.3866.468
  23. Nagai N, Matsumoto T, Kita H, Moritani T. Autonomic nervous system activity and the state and development of obesity in Japanese school children. Obes Res 11: 25-32, 2003 https://doi.org/10.1038/oby.2003.6
  24. Nakagawa T, Ukai K, Ohyama T, Gomita Y, Okamura H. Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamatetreated obese female rats: relationship of antiobesity effect with monoamines. Exp Anim 49:239-249, 2000 https://doi.org/10.1538/expanim.49.239
  25. Nielsen GD. Guanethidine induced sympathectomy in the adult rat. I. Functional effects following subacute administration. Acta Pharmacol Toxicol (Copenh) 41: 203-208, 1977a https://doi.org/10.1111/j.1600-0773.1977.tb02140.x
  26. Nielsen GD. Guanethidine induced sympathectomy in the adult rat. II. Functional effects following chronic administration. Acta Pharmacol Toxicol (Copenh) 41: 209-217, 1977b
  27. Okosun IS, Chandra KM, Choi S, Christman J, Dever GE, Prewitt TE. Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity. Obes Res 9: 1-9, 2001 https://doi.org/10.1038/oby.2001.1
  28. Park SY, Kim YW, Kim JE, Kim JY. Age-associated changes in fat metabolism in the rat and its relation to sympathetic activity. Life Sci 79: 2228-2233, 2006 https://doi.org/10.1016/j.lfs.2006.07.014
  29. Piccirillo G, Vetta F, Fimognari FL, Ronzoni S, Lama J, Cacciafesta M, Marigliano V. Power spectral analysis of heart rate variability in obese subjects: evidence of decreased cardiac sympathetic responsiveness. Int J Obes Relat Metab Disord 20: 825-829, 1996
  30. Piccirillo G, Vetta F, Viola E, Santagada E, Ronzoni S, Cacciafesta M, Marigliano V. Heart rate and blood pressure variability in obese normotensive subjects. Int J Obes Relat Metab Disord 22: 741-750, 1998 https://doi.org/10.1038/sj.ijo.0800650
  31. Reims HM, Fossum E, Hoieggen A, Moan A, Eide I, Kjeldsen SE. Adrenal medullary overactivity in lean, borderline hypertensive young men. Am J Hypertens 17: 611-618, 2004 https://doi.org/10.1016/j.amjhyper.2004.03.676
  32. Scomparin DX, Grassiolli S, Marcal AC, Gravena C, Andreazzi AE, Mathias PC. Swim training applied at early age is critical to adrenal medulla catecholamine content and to attenuate monosodium l-glutamate-obesity onset in mice. Life Sci 79: 2151 -2156, 2006 https://doi.org/10.1016/j.lfs.2006.07.012
  33. Silva JE. Thermogenic mechanisms and their hormonal regulation. Physiol Rev 86: 435-464, 2006 https://doi.org/10.1152/physrev.00009.2005
  34. Sun SJ, Shen ZF, Chen YT, Tang L, Ding SY, Xie MZ. [Effects of conjugated linoleic acid on obese MSG mice with insulin resistanceJ. Yao Xue Xue Bao 38: 904-907, 2003
  35. Takahashi A, Ikarashi Y, Ishimaru H, Maruyama Y. Compensation between sympathetic nerves and adrenal medullary activity: effects of adrenodemedullation and chemical sympathectomy on catecholamine turnover. Life Sci 53: 1567-1572, 1993 https://doi.org/10.1016/0024-3205(93)90565-K
  36. Tataranni PA. From physiology to neuroendocrinology: a reappraisal of risk factors of body weight gain in humans. Diabetes Metab 24: 108-115, 1998
  37. Yoshida T, Nishioka H, Nakamura Y, Kanatsuna T, Kondo M. Reduced norepinephrine turnover in brown adipose tissue of pre-obese mice treated with monosodium-L-glutamate. Life Sci 36: 931-938, 1985 https://doi.org/10.1016/0024-3205(85)90388-1
  38. Zahorska-Markiewicz B, Kuagowska E, Kucio C, Klin M. Heart rate variability in obesity. Int J Obes Relat Metab Disord 17: 21-23, 1993
  39. Zhang WM, Kuchar S, Mozes S. Body fat and RNA content of the VMH cells in rats neonatally treated with monosodium glutamate. Brain Res Bull 35: 383-385, 1994 https://doi.org/10.1016/0361-9230(94)90118-X